Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706849200 on October 2, 2007

J. Biol. Chem., Vol. 282, Issue 48, 35098-35103, November 30, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/48/35098    most recent
M706849200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Golubovic, A.
Right arrow Articles by Gründer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golubovic, A.
Right arrow Articles by Gründer, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Peptide-gated Ion Channel from the Freshwater Polyp Hydra*

Andjelko Golubovic{ddagger}, Anne Kuhn§, Michael Williamson, Hubert Kalbacher||, Thomas W. Holstein§, Cornelis J. P. Grimmelikhuijzen, and Stefan Gründer{ddagger}1

From the {ddagger}Institute of Physiology II, University of Würzburg, D-97070 Würzburg, Germany, §Molecular Evolution and Genomics, Heidelberg Institute of Zoology, D-69120 Heidelberg, Germany, Department of Cell Biology and Comparative Zoology, Institute of Biology, University of Copenhagen, DK-2100 Copenhagen, Denmark, and ||Interfakultäres Institut für Biochemie, University of Tübingen, D-72074 Tübingen, Germany

Received for publication, August 16, 2007 , and in revised form, September 21, 2007.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Chemical transmitters are either low molecular weight molecules or neuropeptides. As a general rule, neuropeptides activate only slow metabotropic receptors. To date, only one exception to this rule is known, the FMRFamide-activated Na+ channel (FaNaC) from snails. Until now FaNaC has been regarded as a curiosity, and it was not known whether peptide-gated ionotropic receptors are also present in other animal groups. Nervous systems first evolved in cnidarians, which extensively use neuropeptides. Here we report cloning from the freshwater cnidarian Hydra of a novel ion channel (Hydra sodium channel, HyNaC) that is directly gated by the neuropeptides Hydra-RFamides I and II and is related to FaNaC. The cells expressing HyNaC localize to the base of the tentacles, adjacent to the neurons producing the Hydra-RFamides, suggesting that the peptides are the natural ligands for this channel. Our results suggest that neuropeptides were already used for fast transmission in ancient nervous systems.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
The DEG/ENaC gene family comprises ion channels with various functions and diverse gating mechanisms (1, 2): the epithelial sodium channel (ENaC)2 is a constitutively open channel, acid-sensing ion channels (ASICs) are gated by extracellular H+, and MEC/degenerin (DEG) channels are mechanically activated channels. The function of many other family members, like the intestinal sodium channel (INaC) (3), is unknown. Arguably the most curious member of this gene family is FaNaC from snails, the only known peptide-gated ion channel, gated by the peptide neurotransmitter Phe-Met-Arg-Phe-NH2 (FMRFamide) (4, 5). Our study was driven by an interest in defining the original properties and gating mechanism of the primitive ancestor of this gene family. BLAST homology searches revealed that the sequenced genomes of bacteria, yeast, and unicellular eukaryotes do not contain genes for DEG/ENaC channels. Thus, it seemed that this gene family evolved later in evolution, perhaps first in multicellular animals, suggesting that the primitive ancestor had a role in intercellular communication.

Hydra belongs to the phylum Cnidaria that is characterized by a radial symmetry and a primitive nervous system that extensively uses neuropeptides for transmission (6). Because all other DEG/ENaC family members characterized to date are from animals with a bilateral symmetry, features common to channels from Hydra and other family members are likely to be primitive features of an ancestral channel that was present in metazoan animals that lived 600-700 million years ago and that were at the base of the Radiata-Bilateria dichotomy. Here we report cloning and characterization of members of the DEG/ENaC gene family from Hydra magnipapillata, revealing a novel peptide-gated ion channel. The presence of related peptide-gated ion channels in Bilateria and Radiata shows that such channels have been present in organisms in which nervous systems first evolved.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Cloning of HyNaC cDNAs—Several partial sequences for proteins showing sequence homology to channels of the DEG/ENaC gene family were identified from the on-line Hydra Expressed Sequence Tag data base and used to design primers for rapid amplification of 5'- and 3'-cDNA ends (RACE). RACE was performed with cDNA prepared from poly(A)+ RNA, isolated from adult one-day starved budding stage H. magnipapillata (strain 105). This strain was a kind gift from Dr. T. Fujisawa (National Institute of Genetics, Mishima, Japan). It was cultured as described previously (7). Full-length HyNaCs were assembled from the 5'- and 3'-RACE products. These sequence data have been submitted to the DDBJ/EMBL/GenBankTM databases under accession Nos. AM393879 [GenBank] (HyNaC1), AM393878 [GenBank] (HyNaC2), AM393880 [GenBank] (HyNaC3), and AM393881 [GenBank] (HyNaC4).

The cDNA for HyNaC1 did not contain a methionine to initiate protein translation upstream of the predicted first transmembrane domain, but it did contain a stop codon there. Moreover, a highly conserved HG motif that is essential for gating of these channels (8) was missing. The absence of an initiator methionine was confirmed by expressed sequence tags from the public data base. Therefore, we conclude that hynac1 is an inactive pseudogene.


Figure 1
View larger version (103K):
[in this window]
[in a new window]

 
FIGURE 1.
Sequence alignment of HyNaCs with rat ASIC1a and rat BLINaC. Amino acids showing a high degree of identity are shown as white letters on black background. The putative positions of transmembrane domains are indicated by bars, conserved cysteines by circles, the completely conserved HG motif, which is important for gating (8, 23), by an open bar, a consensus sequence for N-linked glycosylation that is conserved in all HyNaCs by a branched symbol, and the selectivity filter in the middle of transmembrane domain 2 (22, 25-27) by an open oval. Glycine 444 that was mutated in this study is highlighted by an asterisk. Accession numbers are as follows: rASIC1a, U94403; rBLINaC, Y19034.

 
Analysis of Phylogenetic Relationship—Amino acid sequences of members of the DEG/ENaC gene family were aligned using ClustalX; highly divergent sequences at the N and C termini and in the proximal part of the extracellular loop had been deleted. Phylogenetic trees were constructed by neighbor-joining and parsimony analysis with the program package PAUP*4.0 and by maximum likelihood analysis with the program TREE-PUZZLE.

In Situ Hybridization—Fragments of HyNaC cDNAs, 770-090 bp in length, were subcloned in the vector pBluescript KS. Whole mount in situ hybridization was carried out as previously described (9) by using BMP Purple as substrate for the antibody-conjugated alkaline phosphatase. Three overlapping probes were used for the detection of each transcript at a total probe concentration of 0.39 ng/µl for 60 h.

Electrophysiology—For expression studies in Xenopus oocytes, the entire coding sequences of HyNaC2-4 were amplified by PCR from cDNA of whole Hydras and subcloned. Clones were entirely sequenced to exclude PCR errors. Synthesis of cRNA, maintenance of Xenopus laevis oocytes, and recordings of whole cell currents were done as previously described (10). For co-expression of HyNaC subunits, we injected equal amounts of cRNAs of the individual subunits; the total amount was 5-10 ng.


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 
Cloning of HyNaCs from H. magnipapillata—We isolated four cDNAs with homology to DEG/ENaC channels; we named the corresponding proteins Hydra sodium channels (HyNaC) 1-4. The first member of these channel genes, hynac1, is most likely an inactive pseudogene (see "Experimental Procedures"). The open reading frames of the cDNA clones for HyNaC2-4 code for proteins consisting of 467-470 amino acids with similar predicted molecular masses of ~54 kDa. The degree of amino acid sequence identities between these three HyNaCs ranges from 33 to 67%. They all show the structural hallmarks of the DEG/ENaC gene family: two hydrophobic transmembrane domains, short N and C termini, and a large extracellular loop containing 12 conserved cysteines between the two hydrophobic domains (Fig. 1). For FaNaC, four subunits assemble into the functional channel (11). Three methods were applied to reveal the phylogenetic relationship of HyNaCs to other DEG/ENaC channels: neighbor-joining, parsimony analysis, and maximum likelihood analysis. All three methods consistently placed HyNaCs on a common branch with ASICs and INaC. The tree obtained with maximum likelihood analysis is shown in Fig. 2. The close relationship of HyNaCs to vertebrate genes is in line with a general trend that vertebrate genomes have diverged much less from the bilaterian ancestor than have the genomes of Drosophila and Caenorhabditis elegans (12). This implies that the sequence of the primordial DEG/ENaC gene was similar to HyNaCs/ASICs/INaC. The predicted amino acid sequences of HyNaC2-4 are shown together with the sequences of rat ASIC1a and INaC in Fig. 1. Drosophila and C. elegans have high rates of molecular evolution (12), explaining the many isolated members from these species in the tree shown in Fig. 2.


Figure 2
View larger version (27K):
[in this window]
[in a new window]

 
FIGURE 2.
Quartet-puzzling consensus tree for the DEG/ENaC data set. The tree has been constructed by maximum likelihood analysis with the program TREE-PUZZLE; branch lengths are proportional to the evolutionary distance. Support values below 90% are indicated. The small schematics illustrate the topology and domain organization of different branches of the DEG/ENaC gene family. The ASIC branch is shown also at higher magnification. Abbreviations of species names are as follows: c, chicken (Gallus gallus); f, toadfish (Opsanus tau); h, human (Homo sapiens); Ha, Helix aspersa; Ht, Helisoma trivolvis; Hy, H. magnipapillata; l, lamprey (Lampetra fluviatilis); Ls, Limnea stagnalis; m, mouse (Mus musculus); r, rat (Rattus norvegicus); sh, shark (Squalus acanthias); z, zebrafish (Danio rerio). Other proteins are from Drosophila melanogaster or C. elegans. Accession numbers are as follows: hASIC1a, U78180; rASIC1a, U94403; rASIC1b, AJ309926; shASIC1a, AY956391; shASIC1b, AY956392; cASIC1, AY956393; lASIC1, AY956390; fASIC1, AY278028; fASIC1.2, AY275840; zASIC1.1, AJ609615; zASIC1.2, AJ609616; zASIC1.3, AJ609617; hASIC2a, U50352; hASIC2b, NM_183377; rASIC2a, U53211; rASIC2b, AB049451; fASIC2, AY275841; zASIC2, AJ609618; hASIC3, AF095897; rASIC3, AF013598; hASIC4, AJ271643; rASIC4, AJ271642; zASIC4.1, AJ609619; zASIC4.2, AJ609620; mBLINaC, NM_021370; rBLINaC, Y19034; C18B2.6, NM_076221; C24G7.1, NM_058895; C24G7.2, NM_058894; C24G7.4, NM_058892; C46A5.2, NM_068875; CG8546, NM_139868; CG10858, NM_139569; CG13278, NM_135965; CG15555, NM_143603; DEG-1, L33414; DEL-1, U76403; {alpha}hENaC, X76180; {alpha}rENaC, X70521; βhENaC, X87159; βrENaC, X77932; {gamma}hENaC, X87160; {gamma}rENaC, X77933; {delta}hENaC, U38254; F23B2.3, NM_069189; F28A12.1, NM_072829; HaFaNaC, X92113; HtFaNaC, AF254118; LsFaNaC, AF335548; FLR-1, AB012617; HyNaC1, AM393879; HyNaC2, AM393878; HyNaC3, AM393880; HyNaC4, AM393881; hINaC, AJ252011; MEC-4, X58982; MEC-10, L25312; PPK, Y16225; PPK4, NM_206137; PPK6, NM_137617; PPK7, NM_135172; PPK10, NM_001038805; PPK11, NM_001038798; PPK12, NM_137828; PPK13, NM_001014495; PPK16, NM_001038797; PPK19, AY226547; PPK20, NM_143448; PPK21, NM_143447; PPK23, NM_001014749; PPK25, NM_206044; PPK28, NM_001014748; RPK, Y12640; T28B8.5, NM_059829; T28D9.7, NM_062901; T28F2.7, NM_058795; T28F4.2, NM_059698; UNC-8, U76402; UNC-105, NM_063301; ZK770.1, U97404.

 


Figure 3
View larger version (126K):
[in this window]
[in a new window]

 
FIGURE 3.
hynac genes are expressed at the base of the tentacles. A-F, whole mount in situ hybridization reveals strong expression of hynac2, hynac3, and hynac4 transcripts at the tentacle base in adult animals (A-C) and buds (D-F). G-I, during bud formation hynac2 and hynac3 transcripts appear as soon as tentacles begin to appear (G and H); hynac4 appears later during bud detachment (I).

 
Expression Pattern of HyNaCs—Whole mount in situ hybridization for hynac2-4 revealed expression of all three subunits at the base of the tentacles (Fig. 3), most likely in epitheliomuscular cells. During budding, hynac2 and hynac3 are simultaneously expressed at the sites of tentacle formation, immediately before the first tentacle bumps appear (Fig. 3, G and H). hynac4 expression, however, starts much later when the newly formed bud detaches from the mother polyp and exhibits a strong restriction to the aboral site of the tentacles (Fig. 3I). Arg-Phe-NH2 (RFamide)-containing neurons are present at the tentacle bases, especially neurons expressing the preprohormone A gene that encodes the Hydra-RFamides I-IV (13-15). Hydra neurons are known to make synaptic junctions with epitheliomuscular cells and have dense cored vesicles that contain Hydra-RFamides (16, 17). Although the precise location of HyNaCs is unknown, the above observations suggest that HyNaCs are expressed at the basolateral face of epitheliomuscular cells and that their activation by neuronally released Hydra-RFamides leads to tentacle contractions, possibly during feeding behavior of the animals.

Functional Expression of HyNaCs—We investigated the functional properties of HyNaCs by expression in Xenopus oocytes; cRNA coding for HyNaC2-4 were injected in oocytes either alone or in combination. Expression of HyNaCs did not significantly increase the leak current; rapidly raising the extracellular H+ concentrations also did not activate the channels (not shown). Thus, HyNaCs do not form constitutively active channels like ENaC or H+-gated channels like ASICs. We then tested activation by Hydra-RFamides (18). Rapid application of the structurally similar Hydra-RFamides I or II induced a robust (1-10 µA) inward current in oocytes co-expressing HyNaC2 and HyNaC3 (Fig. 4A). Hydra-RFamides, however, never induced a current in uninjected control oocytes, in oocytes expressing the two subunits individually, or in oocytes expressing other subunit combinations; Hydra-RFamides III and IV never induced any current. Thus, HyNaC2 and 3 form a heteromeric channel gated by Hydra-RFamides I and II. Expressing HyNaC4 in addition to HyNaC2 and 3 did not change the characteristics of the current; the inclusion of HyNaC4 in a heteromeric channel can therefore not be excluded but is not necessary for the formation of the active channel. The effect of Hydra-RFamides I and II was concentration-dependent (Fig. 4B); half-maximal activation was obtained with 34 ± 9 µM (mean ± S.E.; five oocytes) Hydra-RFamide I and 28 ± 4 µM (eight oocytes) Hydra-RFamide II. Thus, the apparent affinity of Hydra-RFamides to their receptor was similar to the affinity of FMRFamide to FaNaC (5, 19) and of low molecular weight ligands to their ionotropic receptors. HyNaC2/3 channels incompletely desensitized (Fig. 4A), similar to FaNaC (5). Repeated application of the peptide induced currents with decreasing amplitudes (Fig. 4C); such a tachyphylaxis is also known from ASIC1a (20).

Currents induced by application of Hydra-RFamide II rose rapidly with a time constant of 170 ms (±50 ms, five oocytes). We estimated the speed of our solution exchange system with oocytes expressing a constitutively open potassium channel (IRK1). Application of a solution where the impermeant Na+ ions were partially replaced by the permeant K+ ions changed the current amplitude with a time constant of 170 ± 30 ms (five oocytes) similar to peptide activation of HyNaC2/3. Hence, Hydra-RFamides induced currents without any apparent delay, suggesting that the speed of activation by peptides of HyNaC2/3 was limited only by solution exchange and not by some additional diffusion-based process that would have been expected if a second messenger cascade were involved in activation of HyNaC2/3.


Figure 4
View larger version (26K):
[in this window]
[in a new window]

 
FIGURE 4.
Electrophysiological characterization of the HyNaC2/3 heteromer. A, top, sequences of the Hydra-RFamide neuropeptides; pQ represents a pyro-Glu. Identical amino acids are highlighted with shaded boxes. Bottom, currents elicited by Hydra-RFamides in Xenopus oocytes injected with HyNaC2 and 3. B, concentration response curve for Hydra-RFamides I and II. C, repeated activation of HyNaC2/3 with Hydra-RFamides led to decreased response; in the example shown, 50 µM Hydra-RFamide I was used. D, replacing Na+ by Li+ or K+ in the bath did not significantly change the current amplitude. Error bars represent S.E. (six oocytes). The composition of the bath solution was as follows (in mM): 140 NaCl (or LiCl or KCl), 1.8 CaCl2, 1 MgCl2, 10 HEPES; HyNaC was activated with 30 µM Hydra-RFamide I. E, voltage ramps for oocytes expressing HyNaC2 and 3 before (-) and during (+) application of 50 µM Hydra-RFamide I. The composition of the bath solution was as in panel D. F, concentration response curve for the inhibition of the HyNaC current by amiloride. Results are from seven oocytes, except for the data point at 5 mM, which is from three oocytes. G, top, sequence alignment of the second putative transmembrane domain of HyNaC2 and 3 and of rat ASIC1a and {alpha}ENaC; the position of the glycine exchanged by a serine in HyNaC3 is indicated by an arrow. Bottom, co-expressing wild-type HyNaC2 with mutant HyNaC3 G444S significantly (p < 0.01; two-tailed t test) reduced the relative amplitude of the K+ current compared with wild-type HyNaC3 (left). Error bars represent S.E. (twelve oocytes). The reversal potential was shifted by ~20 mV to more positive potentials (right); the curves shown have been obtained by subtracting the current before peptide application from the current during peptide application (50 µM Hydra-RFamide I). The composition of the bath solution was as follows (in mM): 140 NaCl (or LiCl or KCl), 0.1 flufenamic acid, 10 HEPES.

 
We did several controls to further exclude indirect activation of HyNaCs. First, we activated a protease-activated receptor that is endogenous to oocytes by applying 10-100 µM trypsin; protease-activated receptor activation raises the intracellular concentration of Ca2+ (21), which could be monitored by a transient inward current due to activation of the Ca2+-activated Cl- channel of oocytes. Second, we increased the concentration of cAMP in oocytes by simultaneously applying isobutyl-methylxanthine (IBMX; 1 mM) and forskolin (50 µM); IBMX inhibits phosphodiesterase and forskolin activates adenylate cyclase. Both maneuvers could not activate any HyNaC-specific current. Third, we inhibited G protein signaling by injection of 23 nl of guanosine 5'-[β-thio]diphosphate (50 mM) in oocytes. Injection of guanosine 5'-[β-thio]diphosphate reduced the protease-activated receptor-induced chloride current by 50% but had only a negligible effect on HyNaC currents (not shown). Fourth, because some effects of RFamides are mediated by opiate receptors, we inhibited opiate receptors by applying 0.5 mM naloxone. Naloxone had no effect on peptide-activated HyNaC currents. In summary, therefore, our results suggest that Hydra-RFamides I and II directly activate HyNaC2/3 by binding to the channel.

Replacing extracellular Na+ by Li+ or K+ did not strongly affect the current amplitude (Fig. 4D), suggesting a channel that does not select between monovalent cations; replacing Na+ by N-methyl-D-glucamine+ abolished inward currents (not shown). The reversal potential was close to 0 mV (Fig. 4E), confirming that HyNaC2/3 is an unselective cation channel. Amiloride inhibited the current only at high concentrations: IC50 was 540 ± 40 µM (±S.E., seven oocytes; Fig. 4F). Thus, HyNaC2/3 has pore properties that are different from other members of the DEG/ENaC gene family. We confirmed that the current induced by the Hydra-RFamides was indeed permeating through the HyNaC2/3 pore by making a mutation within the putative selectivity filter (22): we exchanged glycine 444 by a serine in the middle of predicted transmembrane domain 2 of HyNaC3 (Fig. 1). Co-expression of this mutant channel with wild-type HyNaC2 significantly (p < 0.01; t test) reduced the inward current carried by K+ and shifted the reversal potential by ~20 mV in the positive direction (Fig. 4G). Thus, this pore mutation changed the selectivity of the channel, confirming that HyNaC3 indeed contributes to the ion pore. This result shows that Na+ selectivity is not a common, primitive feature of members of this gene family.

Our results show that the DEG/ENaC gene family contains at least two members that are directly gated by peptides, FaNaC and HyNaCs. These two members are on different branches of the tree (Fig. 2), suggesting that peptide gating is a primitive feature of these channels. The close relation of mammalian ASICs and INaC to HyNaCs then makes these channels candidates for channels directly gated by neuropeptides; the best candidates are the channels with unknown activation mechanism, ASIC4 (23) and INaC (3). Hydra-RFamides did not induce currents in oocytes expressing ASICs or INaC, however, showing that these peptides cannot directly activate the mammalian channels (not shown). FMRFamide also does not directly activate ASICs; pre-application of FMRFamide, however, modulates H+-gated ASIC currents by direct binding to the channel (24). This was also the case for Hydra-RFamides; preapplication of Hydra-RFamides I-IV (50 µM) significantly slowed desensitization of ASIC3 currents (Fig. 5), suggesting that ASIC3 retained a binding site for neuropeptide transmitters that are separated by more than 500 million years of evolution. Because Hydra-RFamides III and IV most strongly modulated ASIC3 currents (Fig. 5) the receptor for these two peptides may also belong to the DEG/ENaC gene family. Peptide modulation of ASIC currents reinforces the speculation that more peptide-gated channels may be hidden within the DEG/ENaC gene family and may contribute to synaptic transmission also in vertebrates.


Figure 5
View larger version (7K):
[in this window]
[in a new window]

 
FIGURE 5.
Hydra-RFamides modulate ASIC3 currents. Pre-application of Hydra-RFamides (50 µM) slowed desensitization of ASIC3 activated with pH 5.5. One example representative for seven different measurements is shown.

 

    FOOTNOTES
 
The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) AM393879 [GenBank] , AM393878 [GenBank] , AM393880 [GenBank] , and AM393881 [GenBank] .

* This work was supported by the Deutsche Forschungsgemeinschaft SFB 488 (to T. W. H.) and the Danish Research Agency (to C. J. P. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Dept. of Physiology II, Röntgenring 9, D-97070 Würzburg, Germany. Tel.: 49-931-31-6046; Fax: 49-931-31-2741; E-mail: stefan.gruender{at}uni-wuerzburg.de.

2 The abbreviations used are: ENaC, epithelial sodium channel; ASIC, acid-sensing ion channel; BLINaC, brain liver intestine sodium channel; DEG, degenerin; FaNaC, FMRFamide-activated Na+ channel; FMRFamide, Phe-Met-Arg-Phe-NH2; HyNaC, Hydra sodium channel; INaC, intestinal sodium channel; RFamide, Arg-Phe-NH2. Back


    ACKNOWLEDGMENTS
 
We thank P. Seeberger for expert technical assistance.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Mano, I., and Driscoll, M. (1999) BioEssays 21, 568-578[CrossRef][Medline] [Order article via Infotrieve]
  2. Kellenberger, S., and Schild, L. (2002) Physiol. Rev. 82, 735-767[Abstract/Free Full Text]
  3. Schaefer, L., Sakai, H., Mattei, M., Lazdunski, M., and Lingueglia, E. (2000) FEBS Lett. 471, 205-210[CrossRef][Medline] [Order article via Infotrieve]
  4. Cottrell, G. A., Green, K. A., and Davies, N. W. (1990) Pflugers Arch. Eur. J. Physiol. 416, 612-614[CrossRef][Medline] [Order article via Infotrieve]
  5. Lingueglia, E., Champigny, G., Lazdunski, M., and Barbry, P. (1995) Nature 378, 730-733[CrossRef][Medline] [Order article via Infotrieve]
  6. Grimmelikhuijzen, C. J. P., Leviev, I., and Carstensen, K. (1996) Int. Rev. Cytol. 167, 37-89[Medline] [Order article via Infotrieve]
  7. Grimmelikhuijzen, C. J. P. (1983) Neuroscience 9, 837-845[CrossRef][Medline] [Order article via Infotrieve]
  8. Gründer, S., Firsov, D., Chang, S. S., Jaeger, N. F., Gautschi, I., Schild, L., Lifton, R. P., and Rossier, B. C. (1997) EMBO J. 16, 899-907[CrossRef][Medline] [Order article via Infotrieve]
  9. Guder, C., Pinho, S., Nacak, T. G., Schmidt, H. A., Hobmayer, B., Niehrs, C., and Holstein, T. W. (2006) Development 133, 901-911[Abstract/Free Full Text]
  10. Paukert, M., Sidi, S., Russell, C., Siba, M., Wilson, S. W., Nicolson, T., and Gründer, S. (2004) J. Biol. Chem. 279, 18783-18791[Abstract/Free Full Text]
  11. Coscoy, S., Lingueglia, E., Lazdunski, M., and Barbry, P. (1998) J. Biol. Chem. 273, 8317-8322[Abstract/Free Full Text]
  12. Raible, F., and Arendt, D. (2004) Curr. Biol. 14, R106-R108[CrossRef][Medline] [Order article via Infotrieve]
  13. Grimmelikhuijzen, C. J. P. (1985) Cell Tissue Res. 241, 171-182[CrossRef]
  14. Hansen, G. N., Williamson, M., and Grimmelikhuijzen, C. J. P. (2000) Cell Tissue Res. 301, 245-253[CrossRef][Medline] [Order article via Infotrieve]
  15. Darmer, D., Hauser, F., Nothacker, H. P., Bosch, T. C., Williamson, M., and Grimmelikhuijzen, C. J. P. (1998) Biochem. J. 332, 403-412[Medline] [Order article via Infotrieve]
  16. Koizumi, O., Wilson, J. D., Grimmelikhuijzen, C. J. P., and Westfall, J. A. (1989) J. Exp. Zool. 249, 17-22[CrossRef][Medline] [Order article via Infotrieve]
  17. Westfall, J. A. (1996) J. Neurocytol. 25, 735-746[CrossRef][Medline] [Order article via Infotrieve]
  18. Moosler, A., Rinehart, K. L., and Grimmelikhuijzen, C. J. P. (1996) Biochem. Biophys. Res. Commun. 229, 596-602[CrossRef][Medline] [Order article via Infotrieve]
  19. Cottrell, G. A., Jeziorski, M. C., and Green, K. A. (2001) FEBS Lett. 489, 71-74[CrossRef][Medline] [Order article via Infotrieve]
  20. Chen, X., and Gründer, S. (2007) J. Physiol. 579, Pt. 3, 657-670[Abstract/Free Full Text]
  21. Schultheiss, M., Neumcke, B., and Richter, H. P. (1997) Cell Mol. Life Sci. 53, 842-849[CrossRef][Medline] [Order article via Infotrieve]
  22. Kellenberger, S., Gautschi, I., and Schild, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4170-4175[Abstract/Free Full Text]
  23. Gründer, S., Geissler, H. S., Bässler, E. L., and Ruppersberg, J. P. (2000) Neuroreport 11, 1607-1611[Medline] [Order article via Infotrieve]
  24. Askwith, C. C., Cheng, C., Ikuma, M., Benson, C., Price, M. P., and Welsh, M. J. (2000) Neuron 26, 133-141[CrossRef][Medline] [Order article via Infotrieve]
  25. Kellenberger, S., Hoffmann-Pochon, N., Gautschi, I., Schneeberger, E., and Schild, L. (1999) J. Gen. Physiol. 114, 13-30[Abstract/Free Full Text]
  26. Snyder, P. M., Olson, D. R., and Bucher, D. B. (1999) J. Biol. Chem. 274, 28484-28490[Abstract/Free Full Text]
  27. Sheng, S., Li, J., McNulty, K. A., Avery, D., and Kleyman, T. R. (2000) J. Biol. Chem. 275, 8572-8581[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Li, Y. Yang, and C. M. Canessa
Interaction of the Aromatics Tyr-72/Trp-288 in the Interface of the Extracellular and Transmembrane Domains Is Essential for Proton Gating of Acid-sensing Ion Channels
J. Biol. Chem., February 13, 2009; 284(7): 4689 - 4694.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/48/35098    most recent
M706849200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Golubovic, A.
Right arrow Articles by Gründer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golubovic, A.
Right arrow Articles by Gründer, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement